Mawson Infrastructure Group Inc (MIGI)

$1.94

+0.3

(+18.29%)

Market is closed - opens 8 PM, 07 Nov 2024

Performance

  • $1.76
    $1.97
    $1.94
    downward going graph

    9.28%

    Downside

    Day's Volatility :10.66%

    Upside

    1.52%

    downward going graph
  • $0.46
    $4.40
    $1.94
    downward going graph

    76.19%

    Downside

    52 Weeks Volatility :89.5%

    Upside

    55.91%

    downward going graph

Returns

PeriodMawson Infrastructure Group IncIndex (Russel 2000)
3 Months
119.16%
0.0%
6 Months
70.18%
0.0%
1 Year
207.94%
0.0%
3 Years
-97.59%
-27.4%

Highlights

Market Capitalization
30.4M
Book Value
$0.25
Earnings Per Share (EPS)
-3.66
Wall Street Target Price
3.0
Profit Margin
-107.21%
Operating Margin TTM
-38.0%
Return On Assets TTM
-32.47%
Return On Equity TTM
-197.88%
Revenue TTM
57.2M
Revenue Per Share TTM
3.41
Quarterly Revenue Growth YOY
24.3%
Gross Profit TTM
36.7M
EBITDA
-10.3M
Diluted Eps TTM
-3.66
Quarterly Earnings Growth YOY
-0.98
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    75%Buy
    25%Hold
    0
    0%Sell
Based on 8 Wall street analysts offering stock ratings for Mawson Infrastructure Group Inc(by analysts ranked 0 to 5 stars)
Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
2
2
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 54.64%

Current $1.94
Target $3.00

Technicals Summary

Sell

Neutral

Buy

Mawson Infrastructure Group Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Mawson Infrastructure Group Inc
Mawson Infrastructure Group Inc
63.03%
70.18%
207.94%
-97.59%
-96.6%
Interactive Brokers Group, Inc.
Interactive Brokers Group, Inc.
15.56%
42.43%
110.38%
133.12%
268.83%
Morgan Stanley
Morgan Stanley
22.16%
37.27%
74.14%
31.4%
170.22%
Tradeweb Markets Inc.
Tradeweb Markets Inc.
-3.23%
16.23%
39.45%
34.89%
209.36%
Charles Schwab Corp., The
Charles Schwab Corp., The
17.83%
0.28%
37.15%
-7.26%
74.14%
Goldman Sachs Group, Inc., The
Goldman Sachs Group, Inc., The
20.49%
34.29%
83.97%
45.95%
166.91%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Mawson Infrastructure Group Inc
Mawson Infrastructure Group Inc
NA
NA
NA
0.0
-1.98
-0.32
NA
0.25
Interactive Brokers Group, Inc.
Interactive Brokers Group, Inc.
23.47
23.62
11.75
6.86
0.22
0.02
0.01
38.25
Morgan Stanley
Morgan Stanley
17.64
17.89
3.41
7.33
0.1
0.01
0.03
56.8
Tradeweb Markets Inc.
Tradeweb Markets Inc.
61.09
62.03
2.97
2.9
0.08
0.07
0.0
26.74
Charles Schwab Corp., The
Charles Schwab Corp., The
27.72
27.75
1.15
3.12
0.12
0.01
0.01
19.01
Goldman Sachs Group, Inc., The
Goldman Sachs Group, Inc., The
14.99
15.46
3.56
36.73
0.1
0.01
0.02
327.61
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Mawson Infrastructure Group Inc
Mawson Infrastructure Group Inc
Buy
$26.9M
-96.6%
NA
-107.21%
Interactive Brokers Group, Inc.
Interactive Brokers Group, Inc.
Buy
$65.1B
268.83%
23.47
14.42%
Morgan Stanley
Morgan Stanley
Hold
$189.9B
170.22%
17.64
19.21%
Tradeweb Markets Inc.
Tradeweb Markets Inc.
Buy
$27.7B
209.36%
61.09
27.52%
Charles Schwab Corp., The
Charles Schwab Corp., The
Buy
$129.8B
74.14%
27.72
27.47%
Goldman Sachs Group, Inc., The
Goldman Sachs Group, Inc., The
Buy
$165.4B
166.91%
14.99
24.65%

Insights on Mawson Infrastructure Group Inc

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 18.77M → 13.11M (in $), with an average decrease of 30.2% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -19.76M → -9.61M (in $), with an average increase of 105.5% per quarter

  • Vs IBKR

    In the last 3 years, Interactive Brokers Group, Inc. has given 132.6% return, outperforming this stock by 230.0%

Institutional Holdings

  • Vident Advisory, LLC

    2.92%
  • Vanguard Group Inc

    1.01%
  • Geode Capital Management, LLC

    0.84%
  • State Street Corp

    0.25%
  • UBS Group AG

    0.19%
  • Millennium Management LLC

    0.17%

Company Information

wize pharma, inc. is a clinical-stage biopharmaceutical company currently focused on the treatment of ophthalmic disorders, including des. wize has in-licensed certain rights to purchase, market, sell and distribute a formula known as lo2a, a drug developed for the treatment of des, and other ophthalmological illnesses, including cch and sjögren's syndrome (sjögren's). lo2a is currently registered and marketed by its inventor in germany and switzerland for the treatment of des, in hungary for the treatment of des, cch and sjögren's and in the netherlands for the treatment of des and sjögren's. wize's strategy involves engaging local or multinational distributors to handle the distribution of lo2a. wize has finished a phase ii trial of lo2a for patients with cch and is currently conducting a phase iv study for lo2a for des in patients with sjögren's.

Organization
Mawson Infrastructure Group Inc
Employees
30
CEO
Mr. Rahul Mewawalla
Industry
Miscellaneous

FAQs